[Ferroptosis-related long non-coding RNA to predict the clinical outcome of non-small cell lung cancer after radiotherapy].

The risk model developed in this study can independently predict the prognosis of NSCLC patients after radiotherapy. This model provides a solid basis for understanding the role of ferroptosis-related lncRNA in the prognosis of NSCLC patients following radiotherapy. Furthermore, it offers clinical guidance for combining radiotherapy with ferroptosis-targeted treatments, potentially improving therapeutic outcomes for NSCLC patients. The integration of genomic and clinical data in this study highlights the importance of personalized medicine approaches in oncology, paving the way for more precise and effective treatment strategies.